Mathematical modelling to identify patients who should not undergo left ventricle remodelling surgery

Richard Warwick1, Mark Pullan, Michael Poullis

  • 1Liverpool Heart and Chest Hospital, Thomas Drive, Liverpool, L14 3PE, UK.

Insights

Left ventricle volume reduction surgery (LVVRS) can be hazardous for dilated cardiomyopathy patients, decreasing cardiac output. However, for left ventricular aneurysm, LVVRS can significantly improve cardiac output and ejection fraction.

Area of Science:

  • Cardiovascular Surgery
  • Mathematical Modeling
  • Cardiac Physiology

Background:

  • Left Ventricle Volume Reduction Surgery (LVVRS) is a procedure aimed at improving cardiac function.
  • The outcomes of LVVRS can vary significantly depending on the underlying cardiac condition.
  • Predictive modeling is crucial for patient selection and optimizing surgical outcomes.

Purpose of the Study:

  • To develop a mathematical model to predict cardiac output after LVVRS.
  • To differentiate surgical candidacy for LVVRS in patients with dilated cardiomyopathy (DCM) versus left ventricular aneurysm (LVA).
  • To assess the impact of LVVRS on cardiac output in different cardiac pathologies.

Main Methods:

  • Development of a mathematical model simulating cardiac output.
  • Inclusion of patient parameters such as left ventricular diastolic volume (LVDV), ejection fraction (EF), and heart rate.
  • Evaluation of two distinct clinical scenarios: DCM and LVA.

Main Results:

  • In DCM, LVVRS led to a decrease in cardiac output (0.7 l/min) with unchanged EF.
  • In LVA, LVVRS resulted in a significant increase in EF (to 56%) and doubled cardiac output.
  • The model demonstrated that LVVRS is potentially hazardous in DCM but beneficial in LVA.

Conclusions:

  • LVVRS carries significant risks for patients with DCM, as supported by registry data.
  • LVVRS can lead to marked improvements in cardiac output for patients with LVA.
  • Preoperative modeling of LV resection extent can predict postoperative cardiac output, aiding surgical decision-making.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...